Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation

Journal of Experimental Medicine

Volumn 206, Issue 11, 2009, Pages 2407-2416

  Das, Jyoti ^a,d   Ren, Guangwen ^a   Zhang, Liying ^a   Roberts, Arthur I ^a   Zhao, Xin ^a   Bothwell, Alfred L M ^b   Van Kaer, Luc ^c   Shi, Yufang ^a,e   Das, Gobardhan ^f  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Institute of Molecular Medicine   (India)

^e SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^f INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; INTERLEUKIN 6; RETINOIC ACID RECEPTOR RELATED ORPHAN NUCLEAR RECEPTOR GAMMAT; STAT4 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CYTOKINE; STAT6 PROTEIN; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GATA3 TRANSCRIPTION FACTOR; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; STAT4 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 70449711235     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082286     Document Type: Article

References (50)

1. Acosta-Rodriguez, E.V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949. doi:10.1038/ni1496
2. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. doi:10.1038/nature04753
3. Burlingham, W.J., R.B. Love, E. Jankowska-Gan, L.D. Haynes, Q. Xu, J.L. Bobadilla, K.C. Meyer, M.S. Hayney, R.K. Braun, D.S. Greenspan, et al. 2007. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J. Clin. Invest. 117:3498-3506. doi:10.1172/JCI28031
4. Choy, E.H., D.A. Isenberg, T. Garrood, S. Farrow, Y. Ioannou, H. Bird, N. Cheung, B. Williams, B. Hazleman, R. Price, et al. 2002. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 46:3143-3150. doi:10.1002/art.10623
5. Das, J., C.H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45-50. doi:10.1038/83158
6. Gijbels, K., S. Brocke, J.S. Abrams, and L. Steinman. 1995. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:795-805.
7. Gorelik, L., and R.A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 12:171-181. doi:10.1016/S1074-7613(00)80170-3
8. Guo, B., E.Y. Chang, and G. Cheng. 2008. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118:1680-1690. doi:10.1172/JCI33342
9. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132. doi:10.1038/ni1254
10. Ivanov, I.I., L. Zhou, and D.R. Littman. 2007. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 19:409-417. doi:10.1016/j.smim.2007.10.011
11. Iwakura, Y., and H. Ishigame. 2006. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116:1218-1222. doi:10.1172/JCI28508
12. Jones, R.E., D.N. Bourdette, R.H. Whitham, H. Offner, and A.A. Vandenbark. 1993. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells. J. Immunol. 150:4620-4629.
13. Kaplan, M.H., Y.L. Sun, T. Hoey, and M.J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:174-177. doi:10.1038/382174a0
14. Khader, S.A., G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, G.E. Cilley, F. Shen, S.M. Eaton, S.L. Gaffen, S.L. Swain, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377. doi:10.1038/ni1449
15. Kikly, K., L. Liu, S. Na, and J.D. Sedgwick. 2006. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18:670-675. doi:10.1016/j.coi.2006.09.008
16. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T.B. Strom, M. Oukka, and V.K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 448:484-487. doi:10.1038/ nature05970
17. Kulkarni, A.B., and S. Karlsson. 1997. Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse. Res. Immunol. 148:453-456. doi:10.1016/S0923-2494(97)82669-7
18. Lafaille, J.J., F.V. Keere, A.L. Hsu, J.L. Baron, W. Haas, C.S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307-312. doi:10.1084/jem.186.2.307
19. Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240. doi:10.1084/jem.20041257
20. Laurence, A., C.M. Tato, T.S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R.B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 26:371-381. doi:10.1016/j.immuni.2007.02.009
21. Li, M.O., Y.Y. Wan, and R.A. Flavell. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity. 26:579-591. doi:10.1016/j.immuni.2007.03.014
22. Lin, W., A. Kemper, J.L. Dupree, H.P. Harding, D. Ron, and B. Popko. 2006. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain. 129:1306-1318. doi:10.1093/brain/awl044
23. + T cells. J. Exp. Med. 205:1381-1393. doi:10.1084/jem.20080034
24. Mangan, P.R., L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 441:231-234. doi:10.1038/nature04754
25. Mathur, A.N., H.C. Chang, D.G. Zisoulis, R. Kapur, M.L. Belladonna, G.S. Kansas, and M.H. Kaplan. 2006. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood. 108:1595-1601. doi:10.1182/blood-2006-04-015016
26. Mattner, F., S. Smiroldo, F. Galbiati, M. Muller, P. Di Lucia, P.L. Poliani, G. Martino, P. Panina-Bordignon, and L. Adorini. 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol. 30:498-508. doi:10.1002/1521-4141(200002)30:2〈498: :AID-IMMU498〉3.0.CO;2-Q
27. Musso, T., I. Espinoza-Delgado, K. Pulkki, G.L. Gusella, D.L. Longo, and L. Varesio. 1990. Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood. 76:2466-2469.
28. Nurieva, R., X.O. Yang, G. Martinez, Y. Zhang, A.D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S.S. Watowich, A.M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 448:480-483. doi:10.1038/nature05969
29. Park, H., Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141. doi:10.1038/ni1261
30. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036. doi:10.1126/science.1078231
31. Paul-Pletzer, K. 2006. Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs Today (Barc). 42:559-576. doi:10.1358/dot.2006.42.9.1025692
32. Pollard, K.M., P. Hultman, and D.H. Kono. 2003. Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity. Ann. NY Acad. Sci. 987:236-239. doi:10.1111/j.1749-6632.2003.tb06053.x
33. Reiner, S.L. 2007. Development in motion: helper T cells at work. Cell. 129:33-36. doi:10.1016/j.cell.2007.03.019
34. Rudner, X.L., K.I. Happel, E.A. Young, and J.E. Shellito. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75:3055-3061. doi:10.1128/IAI.01329-06
35. Samoilova, E.B., J.L. Horton, B. Hilliard, T.S. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-6486.
36. Schett, G. 2008. Review: Immune cells and mediators of inflammatory arthritis. Autoimmunity. 41:224-229. doi:10.1080/08916930701694717
37. Schett, G., and J.P. David. 2008. Denosumab-a novel strategy to prevent structural joint damage in patients with RA? Nat. Clin. Pract. Rheumatol. 4:634-635. doi:10.1038/ncprheum0927
38. Sebba, A. 2008. Tocilizumab: the first interleukin-6-receptor inhibitor. Am. J. Health Syst. Pharm. 65:1413-1418. doi:10.2146/ajhp070449
39. Stockinger, B. 2007. Good for Goose, but not for Gander: IL-2 interferes with Th17 differentiation. Immunity. 26:278-279. doi:10.1016/j.immuni. 2007.03.001
40. Sutton, C., C. Brereton, B. Keogh, K.H. Mills, and E.C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685-1691. doi:10.1084/jem.20060285
41. Tato, C.M., A. Laurence, and J.J. O'Shea. 2006. Helper T cell differentiation enters a new era: le roi est mort; vive le roi! J. Exp. Med. 203:809-812. doi:10.1084/jem.20060522
42. Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179-189. doi:10.1016/j.immuni.2006.01.001
43. Wahl, S.M., and W. Chen. 2003. TGF-beta: how tolerant can it be? Immunol. Res. 28:167-179. doi:10.1385/IR:28:3:167
44. Weaver, C.T., L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 24:677-688. doi:10.1016/j.immuni.2006.06.002
45. Weaver, C.T., R.D. Hatton, P.R. Mangan, and L.E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821-852. doi:10.1146/annurev. immunol.25.022106. 141557
46. Yang, X.O., A.D. Panopoulos, R. Nurieva, S.H. Chang, D. Wang, S.S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358-9363. doi:10.1074/jbc.C600321200
47. Yang, L., D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, M. Oukka, V.K. Kuchroo, and D.A. Hafler. 2008a. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 454:350-352. doi:10.1038/nature07021
48. Yang, X.O., B.P. Pappu, R. Nurieva, A. Akimzhanov, H.S. Kang, Y. Chung, L. Ma, B. Shah, A.D. Panopoulos, K.S. Schluns, et al. 2008b. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 28:29-39. doi:10.1016/j.immuni.2007.11.016
49. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M.L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695-2706. doi:10.1002/eji.200737409
50. Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-974. doi:10.1038/ni1488